Dr. Mussaad M. Al-Razouki

Dr. Razouki is the current Chief Business Development Officer of Kuwait Life Sciences Company (KLSC) where he is part of a team that manages over 50 million dollars in local, regional and international investments on behalf of the Kuwait Investment Authority, the sovereign wealth fund of Kuwait. Dr. Razouki is a regional thought leader within the Middle East life sciences industry having himself shifted from an excellence in clinical practice and research to the management and financing of healthcare systems.

A graduate of Columbia Business School, Dr. Razouki is the first ever Arab national to receive an MBA with a focus on Healthcare Management and Finance.

An Oral and Maxillofacial surgeon by training, Dr. Razouki has completed clinical rotations at the world's top hospitals including New York Presbyterian Hospital of Columbia University Medical Center, Harlem Hospital, Cleveland University Hospital of Case Western Reserve University and Mass General Hospital of Harvard University.

In 2007, Dr. Razouki joined the world's largest and oldest strategic consulting firms, Booz Allen Hamilton, which at the time was operating in over 100 countries across six continents with four billion dollars in revenue. Dr. Razouki was recruited from New York to the Dubai office, where he built the Middle East Healthcare Practice by leading a wide variety of projects across all five dimensions of the healthcare economy including investors, providers (of healthcare services), payors (insurance companies), suppliers (of medical equipment and pharmaceuticals) as well as regulators (governments). Regarding the latter, Dr. Razouki has the distinction of working with every single GCC Ministry of Health as well as both the Dubai Health Authority and the Health Authority of Abu Dhabi.

From 2011 to 2014, Dr. Razouki was the Chief Executive Officer of Kleos Healthcare, a Middle East focused healthcare consulting and development company. Dr. Razouki led the turnaround of Kleos from a docile shell company into a well respected and profitable firm that is widely recognized as a regional authority on Middle East healthcare.

In 2015, Dr. Razouki was selected by Stanford Medicine as part of a group of 20 global authors to write a chapter on digital health investing in the upcoming Springer published book: Digital Health: Scaling Healthcare to the World. He is the only author from the Arab World.

At KLSC, Dr. Razouki has championed the building of strong pillars of the local life sciences ecosystem including the region's premiere pharmaceutical licensing and distribution platform; NewBridge - a 50 mn USD revenue company operating across all 22 MENA countries including Iraq, Iran and Turkey, Clinart – the region's top Clinical Research Organization (CRO) and host of the first-ever Phase II Clinical Trial in the history of Kuwait at the Dasman Diabetes Institute, eCore – the region's top active pharmaceutical ingredients licensor and distributor, the Life Sciences Academy – the region's first-ever training and development company focused on the healthcare and life sciences industry as well as Innomedics – one of Kuwait's top medical device distribution companies that pioneered the distribution of personalized digital health products in the region.

Dr. Razouki and his team have invested and co-invested with some of the world's top life science venture capital funds including, New Leaf Venture Partner in New York, Wellington Partners in Munich and Kearney Venture Partners and Presidio Partners both of which are based in San Francisco. Notable investment direct and indirect investment include: CRISPR Therapeutics - a leading personalized genomic medicine company based in Cambridge, Quanta Fluid Solutions – one of the world's first home hemodialysis manufacturers, and Median Technologies – a leading global provider of medical imaging solutions, especially in the field of oncology.

In 2016, Dr. Razouki was selected by the Abdul Rahman Al Sumait Award Executive Committee to represent the science community in Kuwait and present at the first ever meeting of the committee. The Committee is co-chaired by His Excellency Sheikh Sabah Khalid Al Hamad Al Sabah and Mr. Bill Gates.

Dr. Razouki is also a former advisor to the central Kuwaiti government where he worked with senior government leaders during the administration of HE the Prime Minister, Sheikh Naser Al Mohammad Al Sabah and Deputy Prime Minister for Economic Affairs, Sheikh Ahmed Al Fahad Al Sabah on both Healthcare, Education and Entrepreneurial reforms as part of Kuwait's 100 billion dollar Development Plan. Dr. Razouki continues to work closely with the Council of Minister's of Kuwait and is currently advising the government on the development of the Sabah Al Ahmad National Genome Center together with the Kuwait Foundation for the Advancement of Sciences, a National Pharmaceutical Quality Control Laboratory, 1 bn USD Jaber Hospital project, a 1,168 facility which will be the largest single healthcare structure in the Middle East.

Back to main page